HAYLEY CHAPMAN: Open Payments
NPI 1649934951 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 42 payments from 11 companies in 2025. Trend: 2023 $426 · 2024 $737 · 2025 $845
Food & beverage: $773Education: $72
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $250 |
| Novartis Pharmaceuticals Corporation | 12 | $172 |
| Janssen Biotech, Inc. | 2 | $98 |
| Almirall LLC | 2 | $56 |
| ABBVIE INC. | 3 | $54 |
| LEO Pharma Inc. | 2 | $54 |
| Galderma Laboratories, L.P. | 3 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Organon LLC | 3 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
Products named: Bimzelx, COSENTYX, TREMFYA, Seysara, SKYRIZI, ADBRY, NEMLUVIO, HADLIMA.
Industry payments across AZ — which companies pay providers there.
